Latest publications
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
- NORLUX Neuro-Oncology Laboratory
2019 Aug. Int J Mol Sci.20(17).
Highlights of the inaugural ten - the launch of Neuro-Oncology Advances.
- NORLUX Neuro-Oncology Laboratory
2019 Aug. Neurooncol Adv.1(1):vdz016.
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
- Luxembourg Center of Neuropathology
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
2019 Jul. Brain Pathol.29(4):513-529. Epub 2019 Jan 15.
Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma.
- Computational Biomedicine
- NORLUX Neuro-Oncology Laboratory
2019 Jul. Neuro Oncol.21(7):890–900.
The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment.
- Immuno-Pharmacology and Interactomics
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
2019 Jun. Cells.8(6).
Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes.
- NORLUX Neuro-Oncology Laboratory
2019 Jun. Oncotarget.10(38):3641-3653.
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
- Competence Center for Methodology and Statistics
- Platform National Cytometry
2019 Apr. Nat Commun.10(1):1787.
Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
2019 Apr. Acta Neuropathol Commun.7(1):55.
Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
2019 Apr. Int J Cancer.144(7):1735-1745. Epub 2018 Dec 11.
Irradiation to improve the response to immunotherapeutic agents in glioblastomas.
- NORLUX Neuro-Oncology Laboratory
2019 Apr. Adv Radiat Oncol.4(2):268-282.
A DNA repair and cell-cycle gene expression signature in primary and recurrent glioblastoma: prognostic value and clinical implications.
- DNA Repair and Chemoresistance
- Computational Biomedicine
- NORLUX Neuro-Oncology Laboratory
2019 Mar. Cancer Res.79(6):1226-1238. Epub 2019 Jan 23.
Deciphering the complex role of thrombospondin-1 in glioblastoma development.
- NORLUX Neuro-Oncology Laboratory
2019 Mar. Nat Commun.10(1):1146.
Transcriptional and epigenetic mechanisms underlying astrocyte identity.
- NORLUX Neuro-Oncology Laboratory
2019 Mar. Prog Neurobiol.174:36-52. Epub 2018 Dec 29.
Glioblastoma: a prognostic value of AMT-PET?
- NORLUX Neuro-Oncology Laboratory
2019 Feb. Neuro Oncol.21(2):146-147.
Therapeutic effect of cabazitaxel and blood-brain barrier opening in a patient-derived glioblastoma model.
- NORLUX Neuro-Oncology Laboratory
2019 Feb. Nanotheranostics.3(1):103-112.
The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity.
- NORLUX Neuro-Oncology Laboratory
2019 Jan. Cell Metab.29(1):211-220 e5. Epub 2018 Oct 4.
RNAi/CRISPR Screens: from a Pool to a Valid Hit.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
- DNA Repair and Chemoresistance
2019 Jan. Trends Biotechnol.37(1):38-55. Epub 2018 Aug 31.
Iterative methods for fast reconstruction of undersampled dynamic contrast-enhanced MRI data. In World Congress on Medical Physics and Biomedical Engineering 2018. (Book Chapter)
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
2019 Jan. Ibbott GS, Lhotska L, Sukupova L and Lackovic I, eds. Singapore: Springer Verlag, 2019. p.267-271. (IFMBE, Vol. 68, N°1). ISBN 978-981-10-9034-9 (print); 978-981-10-9035-6 (online).
Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
2018 Nov. EMBO Rep.19(11). Epub 2018 Sep 11.
Revival of the VEGF ligand family?
- NORLUX Neuro-Oncology Laboratory
2018 Oct. Neuro Oncol.20(11):1421-1422.